A 60-year-old man with long-standing type 2 diabetes and microalbuminuria is on ACE inhibitor and SGLT2 inhibitor. His ACR remains 45 mg/mmol. Accordi...

Question

A 60-year-old man with long-standing type 2 diabetes and microalbuminuria is on ACE inhibitor and SGLT2 inhibitor. His ACR remains 45 mg/mmol. According to Diabetes Canada, what additional therapy may further reduce kidney and cardiovascular risk?

Accepted Answer

Add a mineralocorticoid receptor antagonist such as finerenone

Answer

Stop SGLT2 inhibitor

Answer

Use dual RAAS blockade with ACE inhibitor and ARB

Answer

No additional therapy is ever indicated

Answer

Increase protein intake

ca-mccqe1 MCQ (SBA): Diabetic kidney disease

A 60-year-old man with long-standing type 2 diabetes and microalbuminuria is on ACE inhibitor and SGLT2 inhibitor. His ACR remains 45 mg/mmol. According to Diabetes Canada, what additional therapy may further reduce kidney and cardiovascular risk?